Laurus Labs Limited vs Pharmaids Pharmaceuticals Ltd

A side-by-side comparison of Laurus Labs Limited (LAURUSLABS) and Pharmaids Pharmaceuticals Ltd (PHARMAIDSPHARMACEUTICALSLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Laurus Labs Limited leads LAURUSLABS vs PHARMAIDSPHARMACEUTICALSLTD on 10 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability40
  • Growth· not comparable—
  • Size & financial health40

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

125.08
P/E ratio
-24.10
19.74
P/B ratio
2.23
0.10%
Dividend yield
0.00%
₹16.47
EPS
₹-3.32

Profitability

LAURUSLABS takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

16.77%
Return on equity
-26.50%
17.58%
Return on capital
-18.48%
26.09%
EBITDA margin
-48.46%
13.07%
Net margin
-41.50%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

4.09%
Revenue CAGR (3Y) even
—
3.91%
Profit CAGR (3Y) even
—

Size & financial health

LAURUSLABS takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.11L Cr
Market cap
₹106 Cr
₹6,813 Cr
Revenue
₹28 Cr
₹890 Cr
Net profit
₹-12 Cr
0.45
Debt / equity
0.49
Laurus Labs Limited
  • + []
  • − ["Stock is trading at 20.99 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
Pharmaids Pharmaceuticals Ltd
  • + ["Company has reduced debt.", "Debtor days have improved from 56.1 to 44.9 days."]
  • − ["Company has low interest coverage ratio.", "Promoter holding is low: 33.0%", "Company has a low return on equity of -19.4% over last 3 years."]
Laurus Labs Limited full analysis Pharmaids Pharmaceuticals Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.